A
Anat Amit Aharon
Researcher at Tel Aviv University
Publications - 30
Citations - 1219
Anat Amit Aharon is an academic researcher from Tel Aviv University. The author has contributed to research in topics: Medicine & Public health. The author has an hindex of 9, co-authored 23 publications receiving 633 citations. Previous affiliations of Anat Amit Aharon include University of Haifa & Tel Aviv Sourasky Medical Center.
Papers
More filters
Journal ArticleDOI
Efficacy of the BNT162b2 mRNA COVID-19 Vaccine in Patients with Chronic Lymphocytic Leukemia.
Yair Herishanu,Irit Avivi,Anat Amit Aharon,Gabi Shefer,Shai Levi,Yotam Bronstein,Miguel Morales,Tomer Ziv,Yamit Shorer Arbel,Lydia Scarfò,Erel Joffe,Chava Perry,Paolo Ghia +12 more
TL;DR: In this article, the authors evaluated humoral immune responses to the BNT162b2 mRNA COVID-19 vaccine in patients with CLL and compared responses with those obtained in age-matched healthy control subjects.
Journal ArticleDOI
Efficacy of the BNT162b2 mRNA COVID-19 vaccine in patients with B-cell non-Hodgkin lymphoma.
Chava Perry,Chava Perry,Efrat Luttwak,Efrat Luttwak,R. Balaban,Gabi Shefer,Miguel Morales,Anat Amit Aharon,Anat Amit Aharon,Y. Tabib,Yossi Cohen,Yossi Cohen,Noam Benyamini,Noam Benyamini,Ofrat Beyar-Katz,Ofrat Beyar-Katz,M. Neaman,M. Neaman,R. Vitkon,R. Vitkon,N. Keren-Khadmy,Maya Levin,Yair Herishanu,Yair Herishanu,Irit Avivi,Irit Avivi +25 more
TL;DR: In this paper, the humoral immune response to BNT162b2 mRNA COVID-19 vaccine was evaluated in patients with B-NHL who received two vaccine doses 21 days apart and compared with the response in healthy controls.
Journal ArticleDOI
Involvement of microparticles in diabetic vascular complications
TL;DR: It is demonstrated that MP characteristics are related to the specific type of vascular complications and may serve as a bio-marker for the pro- coagulant state and vascular pathology in patients with T2DM.
Journal ArticleDOI
Tissue factor and tissue factor pathway inhibitor levels in trophoblast cells: implications for placental hemostasis.
TL;DR: The procoagulant tendency of STB identified by us may reflect the physiological need for immediate inhibition of hemorrhage in the placental inter-villous spaces in basal and inflammatory conditions.
Journal ArticleDOI
Procoagulant and Anticoagulant Mechanisms in Human Placenta
TL;DR: The placenta is a putative source of coagulation components, however, the interplay between local procoagulant and anticoagULant mechanisms and their association with pregnancy complications need to be assessed.